Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: Oral minoxidil: Low dose oral minoxidil 2.5mg OD and 1.25mg OD in treatment of male and female patterend hair loss respectively
Control Intervention1: Not applicable: Not applicable
Sponsors
DrPSMohanasundari
DrSoundharya
Eligibility
Inclusion criteria
Inclusion criteria: Patient who give consent to the study and followup Patient with age group more than 18 years of both sex Patient diagnosed with Androgenetic alopecia male or female patterned hair loss (having grade I to V Norwood Hamilton scale , I to III Ludwigs scale ) Patient who allows to take photographs.
Exclusion criteria
Exclusion criteria: Patient age less than 18 years of age. Patients not willing to participate in this study. Patient with comorbities such as hypertension , Cardiovascular disorder , renal disease , liver disease, thyroid disorder, hyperandrogenism (PCOS )or another significant Medical condition that may contraindicate the use of minoxidil. Patient with diagnosis other than male and female patterend hair loss Androgenetic alopecia. Patient on treatment with topical minoxidil or any other treament for hairloss. Patient with known hypersensitivity or allergy to Minoxidil . Patient taking medication that interfere with minoxidil such as beta blockers , vasodilators . Patient who have participated in another clinical study involving hair growth treatments within past three months. Pregnancy and lactating mother. Patient with unrealistic expectation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| assess the hair regrowth by measuring hair desnsity and hair count by dermoscopy/phototrichogram.Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| compare the effects of low dose oral minoxidil in male and female pattern hairloss.Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactDrPSMohanasundari
Government Stanley Medical College and Hospital
Outcome results
None listed